David P. Benziger

1.7k total citations
41 papers, 1.4k citations indexed

About

David P. Benziger is a scholar working on Pharmacology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, David P. Benziger has authored 41 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 9 papers in Infectious Diseases and 7 papers in Molecular Biology. Recurrent topics in David P. Benziger's work include Antibiotics Pharmacokinetics and Efficacy (13 papers), Antimicrobial Resistance in Staphylococcus (8 papers) and Aquaculture Nutrition and Growth (4 papers). David P. Benziger is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (13 papers), Antimicrobial Resistance in Staphylococcus (8 papers) and Aquaculture Nutrition and Growth (4 papers). David P. Benziger collaborates with scholars based in United States, Canada and Switzerland. David P. Benziger's co-authors include Sara Yankelev, Gloria Vigliani, Mark Benvenuto, Jerome Edelson, Bruce L. Umminger, Robert F. Kaiko, Charles B. Berde, Feng Gao, Ronald D. Fitzmartin and Robert F. Reder and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

David P. Benziger

39 papers receiving 1.3k citations

Peers

David P. Benziger
Karen I. Plaisance United States
Elaine Radwanski United States
Nieko Punt Netherlands
A. P. Ball United Kingdom
Klaus Borner Germany
David P. Benziger
Citations per year, relative to David P. Benziger David P. Benziger (= 1×) peers Edith Lackner

Countries citing papers authored by David P. Benziger

Since Specialization
Citations

This map shows the geographic impact of David P. Benziger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David P. Benziger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David P. Benziger more than expected).

Fields of papers citing papers by David P. Benziger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David P. Benziger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David P. Benziger. The network helps show where David P. Benziger may publish in the future.

Co-authorship network of co-authors of David P. Benziger

This figure shows the co-authorship network connecting the top 25 collaborators of David P. Benziger. A scholar is included among the top collaborators of David P. Benziger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David P. Benziger. David P. Benziger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bradley, John S., David P. Benziger, Paula M. Bokesch, & Richard F. Jacobs. (2014). Single-dose Pharmacokinetics of Daptomycin in Pediatric Patients 3–24 Months of Age. The Pediatric Infectious Disease Journal. 33(9). 936–939. 27 indexed citations
2.
Burdette, Steven D., et al.. (2014). Dosing strategy to allow continued therapy with daptomycin after asymptomatic increases in creatine kinase levels. American Journal of Health-System Pharmacy. 71(13). 1101–1107. 7 indexed citations
3.
Chaves, Ricardo L., Abhijit Chakraborty, David P. Benziger, & Stacey Tannenbaum. (2013). Clinical and pharmacokinetic considerations for the use of daptomycin in patients with Staphylococcus aureus bacteraemia and severe renal impairment. Journal of Antimicrobial Chemotherapy. 69(1). 200–210. 25 indexed citations
4.
Abdel‐Rahman, Susan M., Gurudatt Chandorkar, Ronda L. Akins, et al.. (2011). Single-dose Pharmacokinetics and Tolerability of Daptomycin 8 to 10 mg/kg in Children Aged 2 to 6 Years With Suspected or Proved Gram-positive Infections. The Pediatric Infectious Disease Journal. 30(8). 712–714. 42 indexed citations
5.
Katz, David, Kimberly C. Lindfield, Judith N. Steenbergen, et al.. (2008). A pilot study of high-dose short duration daptomycin for the treatment of patients with complicated skin and skin structure infections caused by gram-positive bacteria. International Journal of Clinical Practice. 62(9). 1455–1464. 74 indexed citations
6.
Benvenuto, Mark, David P. Benziger, Sara Yankelev, & Gloria Vigliani. (2006). Pharmacokinetics and Tolerability of Daptomycin at Doses up to 12 Milligrams per Kilogram of Body Weight Once Daily in Healthy Volunteers. Antimicrobial Agents and Chemotherapy. 50(10). 3245–3249. 257 indexed citations
7.
Cook, David M., Beverly M. K. Biller, M. L. Vance, et al.. (2002). The Pharmacokinetic and Pharmacodynamic Characteristics of a Long-Acting Growth Hormone (GH) Preparation (Nutropin Depot) in GH-Deficient Adults. The Journal of Clinical Endocrinology & Metabolism. 87(10). 4508–4514. 75 indexed citations
8.
Warren, Katherine E., Mahendra Patel, Alberta Aikin, et al.. (2001). Phase I trial of lobradimil (RMP-7) and carboplatin in children with brain tumors. Cancer Chemotherapy and Pharmacology. 48(4). 275–282. 27 indexed citations
9.
Benziger, David P., et al.. (1998). Prolonged Intercostal Nerve Blockade in Sheep Using Controlled-release of Bupivacaine and Dexamethasone from Polymer Microspheres . Anesthesiology. 89(4). 969–979. 120 indexed citations
10.
Kaiko, Robert F., David P. Benziger, Ronald D. Fitzmartin, et al.. (1996). Pharmacokinetic-pharmacodynamic relationships of controlled-release oxycodone*. Clinical Pharmacology & Therapeutics. 59(1). 52–61. 140 indexed citations
11.
Kaiko, Robert F., et al.. (1996). Clinical Pharmacokinetics of Controlled-Release Oxycodone in Renal Impairment. Clinical Pharmacology & Therapeutics. 59(2). 130–130. 24 indexed citations
12.
Bradford, James C., et al.. (1993). Nephrotoxicity of Pravadoline Maleate (WIN 48098-6) in Dogs: Evidence of Maleic Acid-Induced Acute Tubular Necrosis. Toxicological Sciences. 21(1). 59–65. 1 indexed citations
13.
Hamilton, Robert A., Steven F. Kowalsky, E. M. Wright, et al.. (1986). Effect of the acetylator phenotype on amrinone pharmacokinetics. Clinical Pharmacology & Therapeutics. 40(6). 615–619. 14 indexed citations
14.
McCoy, Leslie F., et al.. (1985). Analysis of amifloxacin in plasma and urine by high-pressure liquid chromatography and intravenous pharmacokinetics in rhesus monkeys. Antimicrobial Agents and Chemotherapy. 27(5). 769–773. 12 indexed citations
15.
Benziger, David P., et al.. (1982). Metabolism of amrinone in animals.. Drug Metabolism and Disposition. 10(2). 168–172. 14 indexed citations
16.
Benziger, David P., et al.. (1981). Metabolism and disposition of sulfinalol in laboratory animals.. Drug Metabolism and Disposition. 9(6). 493–498. 3 indexed citations
17.
Benziger, David P., et al.. (1978). Absorption and disposition of oxarbazole in man and laboratory animals.. Drug Metabolism and Disposition. 6(1). 8–15.
18.
Umminger, Bruce L. & David P. Benziger. (1975). In vitro stimulation of hepatic glycogen phosphorylase activity by epinephrine and glucagon in the brown bullhead, Ictalurus nebulosus. General and Comparative Endocrinology. 25(1). 96–104. 48 indexed citations
19.
Umminger, Bruce L., et al.. (1975). In vitro stimulation of hepatic glycogen phosphorylase activity by epinephrine and glucagon in the killifish, Fundulus heteroclitus. Comparative Biochemistry and Physiology Part C Comparative Pharmacology. 51(1). 111–115. 12 indexed citations
20.
Benziger, David P. & Bruce L. Umminger. (1974). The effect of pH and cold acclimation upon glucose-6-phosphatase activity in the goldfish, Carassius auratus. Comparative Biochemistry and Physiology Part B Comparative Biochemistry. 47(2). 243–254. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026